IL-1R2 as a Precision Therapeutic Target in Sepsis: Molecular Insights into Immune Regulation

Sepsis is a life-threatening condition characterized by systemic inflammation and organ dysfunction, with a complex and not yet fully elucidated molecular basis. Central to its pathogenesis is a dysregulated immune response. In this study, we performed a comprehensive multi-omics analysis on transcr...

Full description

Saved in:
Bibliographic Details
Main Authors: Kirtan Dave, Cristian R. Munteanu
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Current Issues in Molecular Biology
Subjects:
Online Access:https://www.mdpi.com/1467-3045/47/6/429
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849435452320251904
author Kirtan Dave
Cristian R. Munteanu
author_facet Kirtan Dave
Cristian R. Munteanu
author_sort Kirtan Dave
collection DOAJ
description Sepsis is a life-threatening condition characterized by systemic inflammation and organ dysfunction, with a complex and not yet fully elucidated molecular basis. Central to its pathogenesis is a dysregulated immune response. In this study, we performed a comprehensive multi-omics analysis on transcriptomic datasets retrieved from the GEO database, including samples from sepsis patients (<i>n</i> = 23) and healthy controls (<i>n</i> = 27). and identified a pivotal role of Interleukin-1 receptor 2 (IL-1R2) in modulating inflammatory responses in sepsis. Transcriptomic integration revealed activation of critical signaling pathways, including NFκB/NLRP3, associated with sepsis-induced immune dysregulation. We identified a pivotal role of Interleukin-1 receptor 2 (IL-1R2) in modulating inflammatory responses in sepsis, with IL-1R2 showing a 2.1-fold upregulation in septic patients. Transcriptomic integration revealed the activation of 42 significantly enriched signaling pathways, with 26 upregulated and 26 downregulated pathways. Notably, the NFκB/NLRP3 signaling axis emerged as a central hub of immune dysregulation. Gene Ontology (GO) enrichment analysis highlighted “neutrophil activation involved in immune response” as the top biological process. Our findings suggest that IL-1R2 functions as a key immunoregulatory molecule and represents a promising therapeutic target. Moreover, we observed distinct patterns of oxidative stress regulation and immune cell activation, with potential biomarkers correlating with disease severity. These insights not only enhance the molecular understanding of sepsis but also point toward novel precision therapeutic strategies focused on modulating inflammation to improve patient outcomes.
format Article
id doaj-art-44285a0ca8544eb09f5a74c22bdb62a6
institution Kabale University
issn 1467-3037
1467-3045
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Current Issues in Molecular Biology
spelling doaj-art-44285a0ca8544eb09f5a74c22bdb62a62025-08-20T03:26:16ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452025-06-0147642910.3390/cimb47060429IL-1R2 as a Precision Therapeutic Target in Sepsis: Molecular Insights into Immune RegulationKirtan Dave0Cristian R. Munteanu1Parul Institute of Applied Sciences, Parul University, Vadodara 391760, Gujarat, IndiaRNASA, Computer Science Faculty, University of A Coruña, 15071 A Coruña, SpainSepsis is a life-threatening condition characterized by systemic inflammation and organ dysfunction, with a complex and not yet fully elucidated molecular basis. Central to its pathogenesis is a dysregulated immune response. In this study, we performed a comprehensive multi-omics analysis on transcriptomic datasets retrieved from the GEO database, including samples from sepsis patients (<i>n</i> = 23) and healthy controls (<i>n</i> = 27). and identified a pivotal role of Interleukin-1 receptor 2 (IL-1R2) in modulating inflammatory responses in sepsis. Transcriptomic integration revealed activation of critical signaling pathways, including NFκB/NLRP3, associated with sepsis-induced immune dysregulation. We identified a pivotal role of Interleukin-1 receptor 2 (IL-1R2) in modulating inflammatory responses in sepsis, with IL-1R2 showing a 2.1-fold upregulation in septic patients. Transcriptomic integration revealed the activation of 42 significantly enriched signaling pathways, with 26 upregulated and 26 downregulated pathways. Notably, the NFκB/NLRP3 signaling axis emerged as a central hub of immune dysregulation. Gene Ontology (GO) enrichment analysis highlighted “neutrophil activation involved in immune response” as the top biological process. Our findings suggest that IL-1R2 functions as a key immunoregulatory molecule and represents a promising therapeutic target. Moreover, we observed distinct patterns of oxidative stress regulation and immune cell activation, with potential biomarkers correlating with disease severity. These insights not only enhance the molecular understanding of sepsis but also point toward novel precision therapeutic strategies focused on modulating inflammation to improve patient outcomes.https://www.mdpi.com/1467-3045/47/6/429sepsisimmune responseinflammationIL-1R2NFκB signalingbiomarkers
spellingShingle Kirtan Dave
Cristian R. Munteanu
IL-1R2 as a Precision Therapeutic Target in Sepsis: Molecular Insights into Immune Regulation
Current Issues in Molecular Biology
sepsis
immune response
inflammation
IL-1R2
NFκB signaling
biomarkers
title IL-1R2 as a Precision Therapeutic Target in Sepsis: Molecular Insights into Immune Regulation
title_full IL-1R2 as a Precision Therapeutic Target in Sepsis: Molecular Insights into Immune Regulation
title_fullStr IL-1R2 as a Precision Therapeutic Target in Sepsis: Molecular Insights into Immune Regulation
title_full_unstemmed IL-1R2 as a Precision Therapeutic Target in Sepsis: Molecular Insights into Immune Regulation
title_short IL-1R2 as a Precision Therapeutic Target in Sepsis: Molecular Insights into Immune Regulation
title_sort il 1r2 as a precision therapeutic target in sepsis molecular insights into immune regulation
topic sepsis
immune response
inflammation
IL-1R2
NFκB signaling
biomarkers
url https://www.mdpi.com/1467-3045/47/6/429
work_keys_str_mv AT kirtandave il1r2asaprecisiontherapeutictargetinsepsismolecularinsightsintoimmuneregulation
AT cristianrmunteanu il1r2asaprecisiontherapeutictargetinsepsismolecularinsightsintoimmuneregulation